NCCN patient guide urges individualized cancer care for older adults

The National Comprehensive Cancer Network has published a new patient resource designed to help adults over 65 and their caregivers understand why cancer treatment should be tailored to an individual’s health, functional abilities, cognitive needs, other medical conditions and personal priorities rather than determined by chronological age alone. The resource, titled “NCCN Guidelines for Patients: Older Adults With Cancer,” is a plain-language adaptation of NCCN’s clinical practice guidelines for older adult oncology. It is intended to support conversations between patients, caregivers and oncology teams about which assessments may be useful and how treatment choices can be individualized.

The September 17, 2026 announcement is not the report of a new clinical trial and does not present a new outcome comparison between treatments. Instead, it introduces an evidence-based and expert-consensus guideline resource that translates recommendations from NCCN’s clinical guidance into accessible information for patients and caregivers. NCCN describes its clinical practice guidelines as transparent, evidence-based recommendations developed through expert consensus, while its patient guidelines are designed to explain those recommendations in accessible language. The new guide therefore represents a guidance update and communication tool rather than newly collected research data.

“We need to carefully assess any patient over 65, because there can be a huge range in areas such as memory function, physical ability, or treatment interactions with other medications and conditions,” said Efrat Dotan, chair of the NCCN Guidelines Panel for Older Adult Oncology. Her comments reflect the central premise of the new publication: people in the same age category can differ substantially in physical and mental health, and those differences may affect the safety, tolerability and practical delivery of cancer care. The guide also describes ways to support people experiencing cognitive difficulties and those at increased risk of falls, two areas in which the clinical and patient versions provide explanatory information.

Age itself is described as an imperfect proxy for treatment needs. Although the likelihood of side effects and coexisting medical conditions generally increases with age, the guideline stresses that some people remain mentally and physically fit into their 80s, 90s and beyond. The intended audience is people diagnosed with cancer after age 65, although NCCN says the material may also be relevant to younger patients who have additional medical concerns. This distinction is important because the document addresses variation within older populations rather than presenting a uniform treatment pathway for everyone above a specified age.

The clinical and patient versions of the guidance discuss available assessment tools and explain how they can be used to inform decisions. NCCN says the patient resource presents this information in straightforward language with images, a glossary, step-by-step explanations and suggested questions for clinicians. These features are intended to help people understand the information discussed during medical appointments and participate more actively in treatment planning. The guide is available without charge through the NCCN website and the NCCN Patient Guides for Cancer app, with printed copies offered for a nominal fee.

According to Louise C. Walter, chief of geriatrics at UCSF and vice-chair of the NCCN Guidelines Panel for Older Adult Oncology, the aim is to identify the right treatment for the right person in light of that person’s circumstances and preferences. “We all age differently,” Walter said, adding that patients should discuss with their doctors what makes sense for them individually and work toward a plan based on their specific health situations and what they value most. The guidance therefore frames individualized care as the result of an ongoing exchange among patients, caregivers and clinicians rather than as a formula that can be applied without assessment.

Patient advocate Glenn Sykes said the resource could provide practical support to people who face both a cancer diagnosis and the difficulties associated with aging. Recalling his experience caring for his mother after she was diagnosed with cancer at 95, Sykes said caregivers may need help explaining treatment to someone with dementia. He described the prospect of having such guidance available as a potential source of assistance, while expressing hope that it would help others in comparable circumstances. His comments highlight the caregiver dimension addressed by the publication, including the need to communicate treatment information and recognize the additional challenges that can accompany cancer care at advanced ages.

The NCCN patient-guideline series is updated annually in English and Spanish and includes more than 75 resources addressing nearly every cancer type as well as prevention, screening and supportive care subjects such as survivorship, fatigue and distress management. NCCN says the series is intended to help patients and caregivers understand diagnoses and treatment, communicate with clinical teams and make informed decisions. The new older-adult oncology guide extends that effort to a population for which treatment decisions may require particular attention to functional status, cognition, comorbidities, medication interactions, fall risk and individual goals. These are considerations and decision-support topics addressed by the resource, not evidence that a single intervention improves outcomes for all older adults.

For readers seeking to apply the publication, the document frames information gathering as the first step toward shared decision-making. It points to assessment tools, identifies forms of support that may help people with cognitive problems or elevated fall risk, and supplies questions that patients and caregivers can use when speaking with doctors. The resource does not itself establish what treatment a particular person should receive; instead, it explains the clinical topics that may need to be considered and encourages patients to discuss how those topics relate to their own circumstances. NCCN’s public description places the guide within a broader program intended to make evidence-based and expert-consensus cancer guidance understandable to people outside specialist clinics.

The new publication underscores a potentially counterintuitive point for readers accustomed to age-based treatment assumptions: an older age does not by itself dictate a single level of care, and a younger age does not rule out the need for assessment of additional medical concerns. Its practical contribution is to make the reasoning behind individualized oncology care more visible to patients and caregivers. Rather than reporting a new trial or a population-wide change in outcomes, NCCN’s initiative organizes existing clinical guidance around the variability that can occur within older adults and gives patients language and questions for discussing that variability with their care teams.

Subject of Research: NCCN guidance on individualized cancer care and assessment for adults over 65

Article Title: There’s no one-size-fits-all for treating older adults with cancer, according to new NCCN patient resource

Article References: There’s no one-size-fits-all for treating older adults with cancer, according to new NCCN patient resource. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: older adults, cancer care, individualized treatment, geriatric oncology, clinical guidelines, patient decision-making, cognitive impairment, fall risk, comorbidities, patient advocates, There, one-size-fits-all